TGF-β is considered a prototypical SMAD2/3 pathway–activating ligand and a master homeostatic regulator of the respiratory system, with roles in inflammatory and immune regulation21 as well as PAH pathogenesis15,16. This evidence concerns the gene SMAD2 and pulmonary arterial hypertension.